Short Bowel Syndrome

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 1779-1795

  Buchman, Alan L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013034519     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00103-7     Document Type: Chapter

References (152)

1. Buchman AL Complications of long-term home total parenteral nutrition: Their identification, prevention and treatment Dig Dis Sci 46 2001 1-18(Ref 86.)
2. Buchman AL Practical Nutrition Support Techniques 2003 Slack Thorofare, NJ(Ref 87.)
3. Buchman AL., Iyer K., Fryer J Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation Hepatology 43 2006 9-19(Ref 96.)
4. Buchman AL., Moukarzel A Metabolic bone disease associated with total parenteral nutrition Clin Nutr 19 2000 217-231(Ref 115.)
5. Buchman AL., Scolapio J., Fryer J AGA technical review on SBS and intestinal transplantation Gastroenterology 124 2003 1111-1134(Ref 1.)
6. Buchman AL., Sohel M., Dubin M., et al. Choline deficiency causes reversible hepatic abnormalities in patients during parenteral nutrition: Proof of a human choline requirement; a placebo-controlled trial JPEN J Parenter Enteral Nutr 25 2001 260-268(Ref 102.)
7. Cavicchi M., Beau P., Crenn P., et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure Ann Intern Med 132 2000 525-532(Ref 93.)
8. Fryer JP Intestinal transplantation: Current status Gastroenterol Clin N Am 36 2007 145-159(Ref 125.)
9. Jeppesen PB., Hartmann B., Hansen BS., et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure Gut 45 1999 559-563(Ref 31.)
10. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with SBS Gastroenterology 117 1999 1043-1050(Ref 2.)
11. Nordgaard I., Hansen BS., Mortensen PB Importance of colonic support for energy absorption as small-bowel failure proceeds Am J Clin Nutr 64 1996 222-231(Ref 13.)
12. Putchakayala K., Polensky S., Fitzhugh J., et al. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition JPEN J Parenter Enteral Nutr 33 1 2009 55-61(Ref 126.)
13. Roslyn JJ., Pitt HA., Mann LL., et al. Gallbladder disease in patients on long-term parenteral nutrition Gastroenterology 84 1983 148-154(Ref 89.)
14. Scolapio JS., Camilleri M., Fleming CR., et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled trial Gastroenterology 113 1997 1074-1081(Ref 46.)
15. Solhaug JH., Tvete S Adaptive changes in the small intestine following bypass operation for obesity Scand J Gastroenterol 13 1978 401-408(Ref 36.)
16. Woolf GM., Miller C., Kurian R., Jeejeebhoy KN Diet for patients with a short bowel: High fat or high carbohydrate? Gastroenterology 84 1983 823-828(Ref 69.)
17. Buchman AL., Scolapio J., Fryer J AGA technical review on SBS and intestinal transplantation Gastroenterology 124 2003 1111-1134.
18. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with SBS Gastroenterology 117 1999 1043-1050.
19. Carbonnel F., Cosnes J., Chevret S., et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection JPEN J Parenter Enteral Nutr 20 1996 275-280.
20. Andersson H., Bosaeus I., Brummer R-J., et al. Nutritional and metabolic consequences of extensive bowel resection Dig Dis 4 1986 193-201.
21. Crenn P., Haniche M., Valleur P., et al. Surgical versus radiological evaluation of remaining small bowel length (RSBL) in short bowel syndrome (SBS) Gastroenterology 110 1996 A321.
22. Bryant J Observations upon the growth and length of the human intestine Am J Med Sci 167 1924 499-520.
23. Slater G., Aufses AH Jr Small-bowel length in Crohn’s disease Am J Gastroenterol 8 1991 1037-1040.
24. Fanucci A., Cerro P., Fraracci L., Letto F Small-bowel length measured by radiology Gastrointestinal Radiol 9 1984 349-351.
25. Nightingale JMD., Bartram CI., Lennard-Jones JE Length of residual small bowel after partial resection: Correlation between radiographic and surgical measurements Gastrointestinal Radiol 16 1991 305-306.
26. Borgstrom B., Dahlqvist A., Lundh G., Sjovall J Studies of intestinal digestion and absorption in the human J Clin Invest 36 1957 1521-1536.
27. Clarke RM Mucosal architecture and epithelial cell production rate in the small intestine of the albino rat J Anat 107 1970 519-529.
28. Nightingale JM., Lennard-Jones JE., Walker ER., Farthing MJ Jejunal efflux in SBS Lancet 336-8 1990 765-768.
29. Nordgaard I., Hansen BS., Mortensen PB Importance of colonic support for energy absorption as small-bowel failure proceeds Am J Clin Nutr 64 1996 222-231.
30. Royall D., Wolever TMS., Jeejeebhoy KN Evidence for colonic conservation of malabsorbed carbohydrate in SBS Am J Gastroenterol 87 1992 751-756.
31. Nordgaard I., Hansen BS., Mortensen PB Colon as a digestive organ in patients with short bowel Lancet 343 1994 373-376.
32. Ladefoged K., Olgaard K Fluid and electrolyte absorption and renin-angiotensin-aldosterone axis in patients with severe short-bowel syndrome Scand J Gastroenterol 14 1979 729-735.
33. Spiller RC., Jones BJM., Silk DBA Jejunal water and electrolyte absorption from two proprietary enteral feeds in man: Importance of sodium content Gut 28 1987 681-687.
34. Lennard-Jones JE Oral rehydration solutions in SBS Clin Ther 12 1990 129-137.
35. Nightingale JMD., Lennard-Jones JE., Gertner DJ., et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel Gut 33-7 1992 1493.
36. Hylander E., Ladefoged K., Madsen S Calcium balance and bone mineral content following small-intestinal resection Scand J Gastroenterol 16 1981 167-176.
37. Cosnes J., Gendre J-P., Evard D., et al. Compensatory enteral hyperalimentation for management of patients with severe SBS Am J Clin Nutr 41 1985 1002-1009.
38. Hessov I., Andersson H., Isaksson B Effects of a low-fat diet on mineral absorption in small-bowel disease Scand J Gastroenterol 18 1983 551-554.
39. 14C-cholic acid and on the duodenal concentration of bile salts in patients with ileal disease Nutr Metab 20 1976 254-263.
40. Bright-Asare P., Binder H Stimulation of colonic secretion of water and electrolytes by hydroxy fatty acids Gastroenterology 64 1973 81-88.
41. Williams NS., Evans P., King RF Gastric acid secretion and gastrin production in the SBS Gut 26 1985 914-919.
42. Hyman PE., Everett SL., Harada T Gastric acid hypersecretion in SBS in infants: Association with extent of resection and enteral feeding J Pediatr Gastroenterol Nutr 5 1986 191-197.
43. Nightingale JMD., Kamm MA., van der Sijp JR Gastrointestinal hormones in SBS. Peptide YY may be the colonic brake to gastric emptying Gut 39 1996 267-272.
44. Spiller RC., Trotman IF., Higgins BE The ileal brake-inhibition of jejunal motility after ileal perfusion in man Gastroenterology 25 1984 365-374.
45. Holgate AM., Read NW Effect of ileal infusion of intralipid on gastrointestinal transit, ileal flow rate and carbohydrate absorption in humans after ingestion of a liquid meal Gastroenterology 88 1985 1005-1011.
46. Nightingale JMD., Kamm MA., van der Sijp JR., et al. Disturbed gastric emptying in the SBS: Evidence for a “colonic brake.” Gut 34 1993 1171-1176.
47. Jeppesen PB., Hartmann B., Hansen BS., et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure Gut 45 1999 559-563.
48. Jeppesen PB., Hartmann B., Thulesen J., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon Gut 47 2000 370-376.
49. Williamson RCN., Chir M Intestinal adaptation. I. Structural, functional and cytokinetic changes N Engl J Med 298 1978 1393-1402.
50. Williamson RCN., Chir M Intestinal adaptation. II. Mechanisms of control N Engl J Med 298 1978 1444-1450.
51. Appleton GVN., Bristol JB., Williamson RCN Proximal enterectomy provides a stronger systemic stimulus to intestinal adaptation than distal enterectomy Gut 28 1987 165-168.
52. Solhaug JH., Tvete S Adaptive changes in the small intestine following bypass operation for obesity Scand J Gastroenterol 13 1978 401-408.
53. Levy E., Frileux P., Sandrucci S., et al. Continuous enteral nutrition during the early adaptive stage of the SBS Br J Surg 75 1988 549-553.
54. Chaves M., Smith MW., Williamson RCN Increased activity of digestive enzymes in ileal enterocytes adapting to proximal small bowel resection Gut 28 1987 981-987.
55. Gouttebel MC., Saint Aubert B., Colette C., et al. Intestinal adaptation in patients with SBS Dig Dis Sci 34 1989 709-715.
56. Dowling RH Small bowel adaptation and its regulation Scand J Gastroenterol 17 1982 53.
57. Johnson LR., Copeland EM., Diedrich SJ Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats Gastroenterology 68 1975 1177-1183.
58. Briet F., Flourie B., Achour L., et al. Bacterial adaptation in patients with short bowel and colon in continuity Gastroenterology 109 1995 1446-1453.
59. Drucker DJ., Ehrlich P., Asa SL., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2 Proc Natl Acad Sci U S A 93 1996 7911-7916.
60. Rhoads JM., Argenzio RA., Chen W., et al. l-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases Am J Physiol 272 1997 G943-G953.
61. Sham J., Martin G., Meddings JB., Sigalet DL Epidermal growth factor improves nutritional outcome in a rat model of SBS J Pediatric Surg 37 2002 765-769.
62. Scolapio JS., Camilleri M., Fleming CR., et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled trial Gastroenterology 113 1997 1074-1081.
63. Szkudlarek J., Jeppesen PB., Mortensen PB Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: A randomised, double blind, crossover, placebo controlled study Gut 47 2000 199-205.
64. Luk G., Baylin SB Polyamines and intestinal growth-increased polyamine biosynthesis after jejunectomy Am J Physiol 245 1983 G656-G660.
65. Luk G., Baylin SB Inhibition of intestinal epithelial DNA synthesis and adaptive hyperplasia after jejunectomy in the rat by suppression of polyamine biosynthesis J Clin Invest 74 1984 698-704.
66. Nightingdale JMD., Walker ER., Farthing MJG., Lennard-Jones JE Effect of omeprazole on intestinal output in the SBS Aliment Pharmacol Therap 5 1991 405-412.
67. Jeppesen PB., Staun M., Tjellesen L., Mortensen PB Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection Gut 43 1998 763-769.
68. Arrambide KA., Santa Ana CA., Schiller LR., et al. Loss of absorptive capacity for sodium chloride as a cause of diarrhea following partial ileal and right colon resection Dig Dis Sci 34 1989 193-201.
69. Anast CS., Winnacker JL., Forte LR., Burns TW Impaired release of parathyroid hormone in magnesium deficiency Clin Endocrinol Metab 42 1976 707-717.
70. Hylander E., Ladefoged K., Madsen S Calcium balance and bone mineral content following small-intestinal resection Scand J Gastroenterol 16 1981 167-176.
71. O’Keefe SJD., Peterson ME., Fleming CR Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome J Parenter Enter Nutr 18 1994 26-34.
72. Ladefofed K., Christensen KC., Hegnhoj J., Jarnum S Effect of a long-acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe SBS Gut 30 1989 943-949.
73. Niv Y., Charash B., Sperber AD., Oren M Effect of octreotide on gastrostomy, duodenostomy, and cholecystostomy effluents: A physiologic study of fluid and electrolyte balance Am J Gastroenterol 92 1997 2107-2111.
74. Catnach SM., Anderson JV., Fairclough PD., et al. Effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly Gut 34 1993 270-273.
75. Buchman AL., Fryer J., Wallin A., et al. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: A controlled study J Parenter Enter Nutr 30 2006 487-491.
76. Fortran JS Stimulation of active and passive sodium absorption by sugars in the human jejunum J Clin Invest 55 1975 728-737.
77. Pfeiffer A., Schmidt T., Kaess H The role of osmolality in the absorption of a nutrient solution Aliment Pharmacol Ther 12 1998 281-286.
78. Davis GR., Santa Ana CA., Morawski SG., Fortran JC Permeability characteristics of human jejunum, ileum, proximal colon, and distal colon: Results of potential difference measurements and unidirectional fluxes Gastroenterology 83 1982 844-850.
79. Englyst HN., Trowell H., Southgate DAT., Cummings JH Dietary fibre and resistant starch Ann J Clin Nutr 46 1987 873-874.
80. Bond JH., Currier BE., Buchwald H., Levitt MD Colonic conservation of malabsorbed carbohydrate Gastroenterology 78 1980 444.
81. Florent C., Flourie B., Leblond A., et al. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study) J Clin Invest 75 1985 608-613.
82. Little KH., Schiller LR., Bilhartz LE., Fortran JS Treatment of severe steatorrhea with ox bile in an ileectomy patient with residual colon Dig Dis Sci 37 1992 929-933.
83. Fordtran JS., Bunch F., Davis GR Ox bile treatment of severe steatorrhea in an ileectomy-ileostomy patient Gastroenterology 82 1982 564-568.
84. Hoffman AF., Poley R Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection Gastroenterology 62 1972 918-934.
85. Woolf GM., Miller C., Kurian R., Jeejeebhoy KN Diet for patients with a short bowel: High fat or high carbohydrate? Gastroenterology 84 1983 823-828.
86. Ovesen L., Chu R., Howard L The influence of dietary fat on jejunostomy output in patients with severe SBS Am J Clin Nutr 38 1983 270-277.
87. Jeppesen PB., Mortensen PB The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection Gut 43 1998 478-483.
88. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with the SBS Gastroenterology 117 1999 1043-1050.
89. McIntyre PB., Fitchew M., Lennard-Jones JE Patients with a high jejunostomy do not need a special diet Gastroenterology 91 1986 25-33.
90. Woolf GM., Miller C., Kurian R., et al. Nutritional absorption in SBS Dig Dis Sci 32 1987 8-15.
91. Ladefoged K Intestinal and renal loss of infused minerals in patients with severe SBS Am J Clin Nutr 36 1982 59-67.
92. Engels LGJ., van den Hamer CJA., van Tongeren JHM Iron, zinc, and copper balance in short bowel patients on oral nutrition Am J Clin Nutr 40 1984 1038-1041.
93. 2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K Am J Gastroenterol 89 1994 915-923.
94. Wolman SL., Anderson GH., Marliss EB., Jeejeebhoy KN Zinc in total parenteral nutrition: Requirements and metabolic effects Gastroenterology 76 1979 458-467.
95. McFadden MA., Delegge MH., Kirby DF Medication delivery in the SBS JPEN J Parenter Enteral Nutr 17 1993 180-186.
96. Ehrenpreis ED., Guerriero S., Nogueras JJ., Carroll MA Malabsorption of digoxin tablets, gel tabs, and elixir in a patient with an end jejunostomy Ann Pharmacother 28 1994 1239-1240.
97. Levy E., Frileux P., Sandrucci S., et al. Continuous enteral nutrition during the early adaptive stage of the SBS Br J Surg 75 1988 549-553.
98. Cosnes J., Evard D., Beaugerie L., et al. Improvement in protein absorption with a small peptide-base diet in patients with high jejunostomy Nutrition 8 1992 406-411.
99. Marteau P., Messing B., Arrigoni E., et al. Do patients with short-bowel syndrome need a lactose-free diet? Nutrition 13 1997 13-16.
100. Buchman AL., Moukarzel A., Goodson B., et al. Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment JPEN J Parenter Enteral Nutr 18 1994 297-302.
101. Buchman AL., Goodson B., Herzog F., Ament ME Catheter thrombosis and superior/inferior vena cava syndrome are rare complications of long-term parenteral nutrition Clin Nutr 13 1994 356-360.
102. Buchman AL Complications of long-term home total parenteral nutrition: Their identification, prevention and treatment Dig Dis Sci 46 2001 1-18.
103. Buchman AL Practical nutrition support techniques 2003 Slack Thorofare, NJ.
104. Buchman AL., Ament ME Fifteen-year survival of a Broviac catheter used for home parenteral nutrition JPEN J Parenter Enteral Nutr 17 5 1993 489.
105. Roslyn JJ., Pitt HA., Mann LL., et al. Gallbladder disease in patients on long-term parenteral nutrition Gastroenterology 84 1983 148-154.
106. Ling PR., Sheikh M., Boyce P., et al. Cholecystokinin (CCK) secretion in patients with severe SBS (SSBS) Dig Dis Sci 46 2001 859-864.
107. Sitzman JV., Pitt HA., Steinborn PA., et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans Surg Gynecol Obstet 170 1990 25-31.
108. Apelgren KN., Willard DA., Vargish T TPN alters gallbladder responsivity to cholecystokinin JPEN J Parenter Enteral Nutr 12 1988 11S.
109. Cavicchi M., Beau P., Crenn P., et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure Ann Intern Med 132 2000 525-532.
110. Chan S., McCowen KC., Bistrian BR., et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition Surgery 126 1999 28-34.
111. Kelly DA Liver complications of pediatric parenteral nutrition-epidemiology Nutrition 14 1998 153-157.
112. Buchman AL., Iyer K., Fryer J Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation Hepatology 43 2006 9-19.
113. Stegnick LD., Besten LD Synthesis of cysteine from methionine in normal adult subjects: Effect of route of alimentation Science 178 1972 514-516.
114. Stanko RT., Nathan G., Mendelow H., Adibi SA Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition Gastroenterology 92 1987 197-202.
115. Bowyer BA., Fleming CR., Ludwig J., et al. Does long-term parenteral nutrition in adult patients cause chronic liver disease? JPEN J Parenter Enteral Nutr 9 1985 11-17.
116. Buchman AL., Dubin M., Jenden D., et al. Lecithin supplementation causes a decrease in hepatic steatosis in patients receiving long term parenteral nutrition Gastroenterology 102 1992 1363-1370.
117. Buchman AL., Dubin MD., Moukarzel AA., et al. Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation Hepatology 22 1995 1399-1403.
118. Buchman AL., Sohel M., Dubin M., et al. Choline deficiency causes reversible hepatic abnormalities in patients during parenteral nutrition: Proof of a human choline requirement; a placebo-controlled trial JPEN J Parenter Enteral Nutr 25 2001 260-268.
119. Spagnuolo MI., Iorio R., Vegnente A., Guarino A Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: A pilot study Gastroenterology 111 1996 716-719.
120. Lindor KD., Burnes J Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis Gastroenterology 101 1991 250-253.
121. De Marco G., Sordino D., Bruzzese E., et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure Aliment Pharmacol Ther 24 2006 387-394.
122. Gura KM., Lee S., Valim C., et al. Safety and efficacy of a fish-oil based fat emulsion in the treatment of parenteral nutrition-associated liver disease Pediatr 121 2008 e678-e686.
123. Bowyer BA., Miles JM., Haymond MW., Fleming CR l-Carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentration Gastroenterology 94 1988 434-438.
124. Emmett M., Guirl MJ., Santa Ana CA., et al. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in SBS Am J Kidney Dis 41 2003 230-237.
125. Rockwell GF., Campfield T., Nelson BC., Uden PC Oxalogenesis in parenteral nutrition solution components Nutrition 14 1998 836-839.
126. Dahlquist NR., Perrault J., Callaway CW., et al. d-Lactic acidosis and encephalopathy after jejunoileostomy: Response to overfeeding and to fasting in humans Mayo Clin Proc 59 1984 141-146.
127. Oh MS., Uribarri J., Alveranga D., et al. Metabolic utilization and renal handling of d-lactate in men Metabolism 34 1985 621-625.
128. Mayne AJ., Handy DJ., Preece MA., et al. Dietary management of d-lactic acidosis in SBS Arch Dis Child 65 1990 229-231.
129. Hudson M., Pocknee R., Mowat AG d-Lactic acidosis in SBS-an examination of possible mechanisms Q J Med 74 1990 157-163.
130. Buchman AL., Moukarzel A., Ament ME., et al. Serious renal impairment is associated with long-term parenteral nutrition J Parenter Enteral Nutr 17 1993 438-444.
131. Buchman AL., Moukarzel A Metabolic bone disease associated with total parenteral nutrition Clin Nutr 19 2000 217-231.
132. Buchman AL., Sohel M., Brown M., et al. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: A pilot study JPEN J Parenter Enteral Nutr 25 2001 30-35.
133. Idoate MA., Martinez AJ., Bueno J., et al. The neuropathology of intestinal failure and small bowel transplantation Acta Neuropathol 97 1999 502-508.
134. Bianchi A Intestinal loop lengthening-a technique for increasing small intestinal length J Pediatr Surg 15 1980 145-151.
135. Kim HB., Fauza D., Garza J., et al. Serial transverse enteroplasty (STEP): A novel bowel lengthening procedure J Pediatr Surg 38 2003 425-429.
136. Modi BP., Javid PJ., Jaksic T., et al. First report of the international serial transverse enteroplasty data registry: Indications, efficacy, and complications J Am Coll Surg 204 2007 365-371.
137. Wale PW., de Silva N., Langer JC., Fecteau A Intermediate outcomes after serial transverse enteroplasty in children with short bowel syndrome J Pediatric Surg 42 2007 1804-1810.
138. Fishbein TM., Kaufman SS., Florman SS., et al. Isolated intestinal transplantation: Proof of clinical efficacy Transplantation 76 2003 636-640.
139. Lacaille F., Vass N., Sauvat F., et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation Gut 57 2008 455-461.
140. Grant D Intestinal transplantation: 1997 report of the international registry Transplantation 67 1999 1061-1064.
141. Fryer JP Intestinal transplantation: Current status Gastroenterol Clin N Am 36 2007 145-159.
142. Putchakayala K., Polensky S., Fitzhugh J., et al. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition JPEN J Parenter Enteral Nutr 33 1 2009 55-61.
143. Byrne TA., Persinger RL., Young LS., et al. A new treatment for patients with short-bowel syndrome-growth hormone, glutamine, and a modified diet Ann Surg 222 1995 243-254.
144. Ellegard L., Bosaeus I., Nordgren S., Bengtsson BA Low-dose recombinant growth hormone increases body weight and lean body mass in patients with SBS Ann Surg 225 1997 88-96.
145. Seguy D., Vahedi K., Kapel N., et al. Low dose growth hormone in adult home parenteral nutrition-dependent SBS patients: A positive study Gastroenterology 124 2003 293-302.
146. Jeppesen PB., Hartmann B., Thulesen J., et al. Treatment of short bowel patients with glucagon-like peptide 2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide Gastroenterology 118 2000 A178.
147. Jeppesen PB., Sanguinetti EL., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients Gut 54 2005 1224-1231.
148. O’Keefe SJ., Gilroy R., Jeppesen PB., et al. Teduglutide, a novel GLP-2 analog in the management of short bowel syndrome (SBS) in patients dependent on parenteral nutrition: A multicenter, multinational placebo-controlled clinical trial [abstract] Gastroenterology 134 2008 A37.
149. Jeppesen PB., Gottschalck I., Holst JJ., Mortensen PB Improvements in renal function in short bowel syndrome (SBS) patients treated for two years with subcutaneous native glucagon-like peptide 2 (GLP-2) [abstract] Gastroenterology 2008.
150. Lauverjat M., Hadj AA., Vanhems P., et al. Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition Clin Nutr 25 2006 75-81.
151. Byrne TA., Wilmore DW., Iyer K., et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: A prospective, randomized, placebo-controlled, double-blind clinical trial Ann Surg 242 2005 655-661.
152. Scolapio JS., Fleming CR., Kelly DG., et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic Mayo Clin Proc 74 1999 217-222.